Breaking News Instant updates and real-time market news.

BIIB

Biogen

$303.78

-1.42 (-0.47%)

04:55
11/29/16
11/29
04:55
11/29/16
04:55

Biogen management to meet with Leerink

Meeting to be held in Boston on November 29 hosted by Leerink.

  • 29

    Nov

BIIB Biogen
$303.78

-1.42 (-0.47%)

11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Overweight
Piper's Schimmer proclaims amyloid hypothesis is not dead
Piper Jaffray analyst Joshua Schimmer says the failure of Eli Lilly's (LLY) solanezumab is not the final nail in the amyloid hypothesis coffin. Biogen (BIIB) and Eisai's aducanimab study is the most potent approach for amyloid lowering, Schimmer tells investors in a research note. He points out that he was skeptical whether solanezumab's effect was adequate. "Our view of Alzheimer's for amyloid is informed not so much by the extremely sloppy science in that disease, but by consistent cause/effect signals across other amyloidosis," Schimmer writes. He believes today's selloff in shares of Biogen "creates some breathing room." The analyst recommends looking to build a position in Biogen after the stock settles down. Schimmer reiterates an Overweight rating on the shares with a $335 price target. The stock is down 8%, or $24.41, to $293.70 in pre-market trading.
11/23/16
MSCO
11/23/16
NO CHANGE
MSCO
Overweight
Morgan Stanley expects big reversal today in Biogen shares
Morgan Stanley Matthew Harrison expects shares of Biogen (BIIB) to end the trading day flat or slightly higher. The stock is currently down $26.61, or 8%, to $291.50 in pre-market trading. With Biogen's aducanumab more potent than Eli Lilly's solanezumab, the Alzheimer's drug still has potential for success, Harrison tells investors in a research note. He points out that Lilly management noted that "the study results, including many secondary clinical endpoints, directionally favored solanezumab." Harrison sees hope in the amyloid hypothesis. The analyst has an Overweight rating on Biogen.
11/23/16
SBSH
11/23/16
NO CHANGE
Target $305
SBSH
Buy
Citi sees four reasons why Biogen Alzheimer's drug can still work
Citi analyst Robyn Karnauska sees four reasons why Biogen's (BIIB) Alzheimer's drug aducanumab can still work following the failure of Eli Lilly's (LLY) solanezumab. The analyst lists difference in mechanism of action, efficacy in an end-point-dependent manner, patient population and endpoints as why she thinks Biogen's drug can have a different outcome than Lilly's. The analyst has a Neutral rating on Biogen with a $305 price target.
11/23/16
JEFF
11/23/16
NO CHANGE
Target $310
JEFF
Buy
Biogen selloff may be an overreaction, says Jefferies
Jefferies analyst Brian Abrahams believes selloff in shares of Biogen (BIIB) following Eli Lilly's (LLY) Alzheimer's failure may be an overreaction. Signals of activity seen for Lilly's sola "do maintain some possibility" that Biogen's aducanumab could "ultimately make it over the line," Abrahams tells investors in a research note. He keeps a Hold rating on Biogen with a $310 price target, however, viewing the risk/reward as balanced.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

12:17
11/21/17
11/21
12:17
11/21/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$115.81

0.9 (0.78%)

, KHC

Kraft Heinz

$79.93

0.3 (0.38%)

12:16
11/21/17
11/21
12:16
11/21/17
12:16
Periodicals
PepsiCo speculated as possible Kraft Heinz target, FT says »

CreditSights suggests…

PEP

PepsiCo

$115.81

0.9 (0.78%)

KHC

Kraft Heinz

$79.93

0.3 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
11/21/17
11/21
12:16
11/21/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$26.70

-0.04 (-0.15%)

12:10
11/21/17
11/21
12:10
11/21/17
12:10
Options
Size ratio call spread adds 50K contracts to Bank of America volume »

Size ratio call spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$83.54

-2.36 (-2.75%)

12:08
11/21/17
11/21
12:08
11/21/17
12:08
Hot Stocks
Tesaro higher after announcing 'non-dilutive' financing »

Tesaro announced earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

SU

Suncor

$35.28

0.34 (0.97%)

12:05
11/21/17
11/21
12:05
11/21/17
12:05
Options
Suncor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

12:00
11/21/17
11/21
12:00
11/21/17
12:00
General news
FX Action: USD-CAD »

FX Action: USD-CAD pulled…

11:55
11/21/17
11/21
11:55
11/21/17
11:55
General news
Treasury's $13 B 2-year FRN stopped at a high discount margin of 0.035% »

Treasury's $13 B…

TRIP

TripAdvisor

$30.48

-0.11 (-0.36%)

11:50
11/21/17
11/21
11:50
11/21/17
11:50
Options
TripAdvisor calls outpace puts 10:1 as shares see relative strength »

TripAdvisor calls outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$61.70

-0.02 (-0.03%)

11:48
11/21/17
11/21
11:48
11/21/17
11:48
Conference/Events
Royal Dutch Shell to hold a meeting »

2017 Management Day will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKRX

Akorn

11:48
11/21/17
11/21
11:48
11/21/17
11:48
Periodicals
Akorn spokesperson tells Bloomberg no change with Fresenius SE deal »

As previously reported,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$109.11

1.735 (1.62%)

11:45
11/21/17
11/21
11:45
11/21/17
11:45
Earnings
On The Fly: What to watch in Salesforce earnings report »

Salesforce (CRM) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

11:45
11/21/17
11/21
11:45
11/21/17
11:45
General news
Euro$ interest rate futures continue to recline »

Euro$ interest rate…

JNJ

Johnson & Johnson

$138.81

0.88 (0.64%)

11:44
11/21/17
11/21
11:44
11/21/17
11:44
Hot Stocks
Janssen announces submission of sBLA to expand indication for Darzalex »

Janssen Biotech, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BLMN

Bloomin' Brands

$20.54

2.27 (12.42%)

11:40
11/21/17
11/21
11:40
11/21/17
11:40
Hot Stocks
Bloomin' Brands says will consider JANA Partners' perspectives »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGP

Plains GP Holdings

$20.85

-0.04 (-0.19%)

11:40
11/21/17
11/21
11:40
11/21/17
11:40
Options
Call writer opens a notable new position in Plains GP Holdings »

Call writer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$194.10

0.9 (0.47%)

, T

AT&T

$34.49

-0.155 (-0.45%)

11:34
11/21/17
11/21
11:34
11/21/17
11:34
Hot Stocks
FCC chairman Ajit Pai circulates draft Restoring Internet Freedom Order »

FCC chairman Ajit Pai…

NFLX

Netflix

$194.10

0.9 (0.47%)

T

AT&T

$34.49

-0.155 (-0.45%)

VZ

Verizon

$46.31

0.105 (0.23%)

CHTR

Charter

$338.37

-3.17 (-0.93%)

CMCSA

Comcast

$35.83

-0.33 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

MU

Micron

$47.64

1.48 (3.21%)

11:30
11/21/17
11/21
11:30
11/21/17
11:30
Options
Large four-way spread in Micron as shares see strength »

Large four-way spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Dec

NFLX

Netflix

$194.10

0.9 (0.47%)

, T

AT&T

$34.44

-0.205 (-0.59%)

11:23
11/21/17
11/21
11:23
11/21/17
11:23
Periodicals
FCC Chair proposes to scrap existing net neutrality rules, Bloomberg reports »

FCC Chairman Ajit Pai has…

NFLX

Netflix

$194.10

0.9 (0.47%)

T

AT&T

$34.44

-0.205 (-0.59%)

VZ

Verizon

$46.34

0.14 (0.30%)

CMCSA

Comcast

$35.83

-0.33 (-0.91%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

ILG

ILG

$28.61

-0.51 (-1.75%)

11:20
11/21/17
11/21
11:20
11/21/17
11:20
Options
Second day of interest in ILG longer-dated puts »

Second day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

  • 01

    Dec

PANW

Palo Alto Networks

$152.93

10.4 (7.30%)

11:18
11/21/17
11/21
11:18
11/21/17
11:18
Upgrade
Palo Alto Networks rating change  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

OCLR

Oclaro

$6.49

-0.09 (-1.37%)

11:17
11/21/17
11/21
11:17
11/21/17
11:17
Hot Stocks
Oclaro announces participation in upcoming investor conferences »

Oclaro announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 12

    Dec

$NSD

NASDAQ Market Internals

11:17
11/21/17
11/21
11:17
11/21/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
11/21/17
11/21
11:16
11/21/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/21/17
11/21
11:15
11/21/17
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.